Well Told Grants

Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-PS-24-042: A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison

Closed Closed March 1, 2024 Opportunity RFA-PS-24-042

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.

Centers for Disease Control and Prevention - ERA offered grants of up to $375,000 (at least $285,000) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expected to make about 2 awards worth $3.0 million in total. Applications closed on March 1, 2024.

From the official notice on Grants.gov, last changed December 1, 2023. Checked November 7, 2026.

Key dates

PostedDecember 1, 2023
DeadlineMarch 1, 2024
Archived by Grants.govMarch 31, 2024

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes and businesses.

All 14 applicant types the notice lists

N/A

More grants for nonprofits, colleges and universities, state and local governments, tribes, businesses.

Is this a realistic fit?

What the grant funds

Each year, approximately 6,500 persons with HIV living in prison facilities are released to the community, often lacking support for ongoing HIV care. There is a paucity of programming for this population that demonstrates effective retention in HIV care and sustained HIV viral suppression after release. The use of long-acting injectable antiretroviral therapy (LAI-ART) prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. The primary purpose of this Notice of Funding Opportunity (NOFO) is to support the development and implementation of effective, sustainable, replicable LAI-ART programs for prison facilities and to understand the feasibility and acceptability of providing LAI-ART to persons with HIV living in prisons who are to be released to the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.

Category: Health.

Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before

From fiscal 2021 to 2025, Prevention of Disease, Disability, and Death by Infectious Diseases (93.084) awarded $241 million across 128 grant awards, an average of $1.9 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Puerto Rico Science, Technology, and Research TrustPuerto Rico4$14.5 million
Massachusetts Department of Public HealthMassachusetts1$11.6 million
Emory UniversityGeorgia3$11.5 million
Uganda Virus Research Institute1$8.7 million
Ponce Medical School Foundation IncPuerto Rico2$8.7 million

Top states: Massachusetts ($26.4 million), Puerto Rico ($23.2 million), California ($22.9 million), Georgia ($20.0 million), Maryland ($14.0 million).

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-PS-24-042 still open?

No. It closed on March 1, 2024. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

Who can apply for A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison?

Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison?

Closed March 1, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $375,000 each. About $3.0 million in total across about 2 awards.

Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before?

The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.

Similar open grants